Popular Posts

Total Downloads Worldwide

Tuesday 25 October 2011

"TRIAL AND ERROR APPROACH TO DIAGNOSIS." RESEARCHER BLOWS WHISTLE ON CURRENT MEDICAL PRACTICE WITH ADHD DIAGNOSIS

FRIDAY, Oct. 21 (HealthDay News) — 

Children with specific gene variants respond better to the drug methylphenidate (Ritalin, Concerta), which is widely used to treat attention-deficit hyperactivity disorder (ADHD), a new study says.

The finding could help improve treatment of ADHD, according to the Cincinnati Children's Hospital Medical Center researchers.

"Physicians don't have a good way of predicting who will experience great improvement in ADHD symptoms with a particular medication, so currently we use a trial-and-error approach. Unfortunately, as a result, finding an effective treatment can take a long time," lead investigator Dr. Tanya Froehlich, a physician in the division of developmental and behavioral pediatrics, said in a medical center news release.

No comments:

Post a Comment

PLEASE ADD COMMENTS SO I CAN IMPROVE THE INFORMATION I AM SHARING ON THIS VERY IMPORTANT TOPIC.